![[R logo]](../../../doc/html/logo.jpg){kind=logo}
![[Up]](../../../doc/html/left.jpg){kind=small}
![[Top]](../../../doc/html/up.jpg){kind=small}
| curatedOvarianData | Clinically Annotated Data for the Ovarian Cancer Transcriptome |
| E.MTAB.386_eset | Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer. |
| GSE12418_eset | Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. |
| GSE12470_eset | Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis. |
| GSE13876_eset | Survival-related profile, pathways, and transcription factors in ovarian cancer. |
| GSE14764_eset | A prognostic gene expression index in ovarian cancer - validation across different independent data sets. |
| GSE17260_eset | Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets. |
| GSE18520_eset | A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. |
| GSE19829.GPL570_eset | Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. |
| GSE19829.GPL8300_eset | Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. |
| GSE20565_eset | A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. |
| GSE2109_eset | IGC EXpression Project for Oncology |
| GSE26712_eset | A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. |
| GSE30009_eset | Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma. |
| GSE30161_eset | Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance. |
| GSE32062.GPL6480_eset | High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. |
| GSE32063_eset | High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. |
| GSE6008_eset | Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis. |
| GSE6822_eset | Classification of ovarian tumor samples |
| GSE9891_eset | Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. |
| PMID15897565_eset | Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. |
| PMID17290060_eset | An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer. |
| PMID19318476_eset | Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. |
| TCGA.mirna.8x15kv2_eset | Integrated genomic analyses of ovarian carcinoma. |
| TCGA_eset | Integrated genomic analyses of ovarian carcinoma. |